HOLOTHURIA SCABRA METHANOL EXTRACT INHIBITS CANCER GROWTH THROUGH TGF-β/PI3K/PTEN SIGNALING PATHWAY IN BREAST CANCER MICE MODEL
DOI:
https://doi.org/10.15407/exp-oncology.2024.01.022Keywords:
anticancer activity, breast cancer, Holothuria scabra, TGF-β/PIK3CA, PTENAbstract
Background. Molecules and cytokines can be targeted in cancer therapy. Transforming growth factor-beta (TGF-β) is a cytokine that acts on protein kinase receptors in the plasma membrane. The signaling pathway of TGF-β can trigger the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) pathway, a signal transduction pathway important in cancer growth and development. However, this PI3K/AKT cascade can be inhibited by phosphatase and tensin homolog (PTEN) tumor suppressor genes. Aim. To determine the inhibitory effect of Holothuria scabra methanol extract (HSE) on breast cancer growth through the TGF-β/PI3K pathways and PTEN tumor suppressor gene on a breast cancer (BC) mice model. Materials and Methods. Female C57BL6 mice were subcutaneously injected with carcinogen DMBA 1 mg/kg body weight (BW) and fed a high-fat diet (HFD). Mice were randomly divided into five groups (n = 6): negative control (NC) administered with a standard diet, positive control (PC) administered with DMBA and HFD, and three treatment groups (T1, T2, and T3) treated with HSE doses of 0.33, 0.66, and 0.99 g/kg BW for 12 weeks. TGF-β concentration in the blood serum of mice was assessed by ELISA and the PIK3CA and PTEN gene expression by qRT-PCR. Results. The treatment with HSE resulted in a significant decrease in TGF-β concentrations in the blood sera of treatment groups T1 (35.31 ± 17.33), T2 (43.31 ± 17.42), and T3 (48.67 ± 20.94) pg/mL compared to the PC group (162.09 ± 11.60) pg/mL (p < 0.001). However, only HSE at a dose of 0.99 g/kg BW decreased the PIK3CA gene expression (p = 0.026), and at a dose of 0.66 g/kg BW increased the PTEN expression up to 4.93-fold. Conclusion. HSE is capable of inhibiting the TGF-β/PIK3CA pathway and increasing the PTEN gene expression.
References
Calone I, Souchelnytskyi S. Inhibition of TGFβ signaling and its implications in anticancer treatments. Exp Oncol. 2012;34(1):9-16.
Khoshakhlagh M, Soleimani A, Binabaj MM, et al. Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer. Biochem Pharmacol. 2019;164:17-22. https://doi.org/10.1016/j.bcp.2019.03.031
Fujio K, Komai T, Inoue M, et al. Revisiting the regulatory roles of the TGF-β family of cytokines. Autoimmun Rev. 2016;15(9):917-922. https://doi.org/10.1016/j.autrev.2016.07.007
Ghayad S, Cohen P. Inhibitors of the PI3K/Akt/mTOR Pathway: new hope for breast cancer patients. Recent Pat Anticancer Drug Discov. 2010;5(1):29-57. https://doi.org/10.2174/157489210789702208
Crowder RJ, Phommaly C, Tao Y, et al. PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer. Cancer Res. 2009;69(9):3955-3962. https://doi.org/10.1158/0008-5472
Luongo F, Colonna F, Calapà F, et al. PTEN tumor-suppressor: the dam of stemness in cancer. Cancers. 2019;11(8):1076. https://doi.org/10.3390/cancers11081076
Pangestuti R, Ari Z. Benefit effects of functional sea cucumbers. J Tradit Complement Med. 2018;8(3):341-351. https://doi.org/10.1016/j.jtcme.2017.06.007
Wargasetia TL, Ratnawati H, Widodo N. Anticancer potential of Holothurin A, Holothurin B, and Holothurin B3 from the sea cucumber Holothuria scabra. AIP Conf Proc. 2020:2231. https://doi.org/10.1063/5.0002552
Hoang L, Le Thi V, Tran Thi Hong H, et al. Triterpene glycosides from the Vietnamese sea cucumber Holothuria edulis. Nat Prod Res. 2020;34(8):1061-1067. https://doi.org/10.1080/14786419.2018.1548451
Cranford TL, Velázquez KT, Enos RT, et al. Effects of high fat diet-induced obesity on mammary tumorigenesis in the PyMT/MMTV murine model. Cancer Biol Ther. 2019;3;20(4):487–496. doi:10.1080/15384047.2018.1537574
Kinoshita Y, Yoshioka M, Emoto Y, et al. Dietary effect of mead acid on DMBA-induced breast cancer in female Sprague–Dawley rats. Int J Funct Nutr. 2020;1(2):1. https://doi.org/10.3892/ijfn.2020.7
Simpson JF, Gray R, Dressler LG, et al. Prognostic value of histologic grade and proliferative activity in axillary node–positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol. 2000;18(10):2059-2069. https://doi.org/10.1200/JCO.2000.18.10.2059
Purcell S, Samyn Y, Conand C. Commercially important sea cucumbers of the world. 2012;6:150 p. https://doi.org/10.4060/cc5230en
Li M, Zhang W, Yang L, et al. The mechanism of Xiaoyao San in the treatment of ovarian cancer by network pharmacology and the effect of stigmasterol on the PI3K/Akt pathway. Dis Markers. 2021:4304507. https://doi.org/10.1155/2021/4304507
Wargasetia TL, Ratnawati H, Liana LK, et al. Holothuria scabra extract improves histopathological features and inhibits cancer growth through IL-6 and NF κ B signaling pathways in carcinoma mammae mice model. Res J Pharmacogn. 2024;11(2):1-9. https://doi.org/10.22127/rjp.2023.417833.2233
Xie F, Ling L, Van Dam H, et al. TGF-beta signaling in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 2018;50(1):121-132. https://doi.org/10.1093/abbs/gmx123
Gillespie C, Quarshie A, Penichet M, et al. Potential role of leptin signaling in DMBA induced mammary tumors by non-responsive C57BL/6J Mice Fed a high-fat diet. J Carcinog Mutagen. 2012;3(132):20-23. https://doi.org/10.4172/2157-2518.1000132
Rosdianto AM, Kurniawan A, Gunadi JW, et al. DMBA-induced modulate estrogen receptors α and β breast cancer’s animal model. Maj Kedokt Bandung. 2022;54(1):37-42. https://doi.org/10.15395/mkb.v54n1.2479
Abba MC, Zhong Y, Lee J, et al. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations. Oncotarget. 2016;7(39):64289-64299. https://doi.org/10.18632/oncotarget.11733
Wargasetia TL, Ratnawati H, Widodo N. Anticancer potential of Holothurin A, Holothurin B, and Holothurin B3 from the sea cucumber Holothuria scabra. In: AIP Conf Proc. 2020;2231:040084. https://doi.org/10.1063/5.0002552
Khotimchenko Y. Pharmacological potential of sea cucumbers. Int J Mol Sci. 2018;19(5):1342. https://doi.org/10.3390/ijms19051342
Batlle E, Massagué J. Transforming growth factor-β Signaling in immunity and cancer. Immunity. 2019;50(4):924-940. https://doi.org/10.1016/j.immuni.2019.03.024
Chen Y, Di C, Zhang X, et al. Transforming growth factor β signaling pathway: A promising therapeutic target for cancer. J Cell Physiol. 2020;235(3):1903-1914. https://doi.org/10.1002/jcp.29108
Song K, Wang H, Krebs TL. Novel roles of Akt and mTOR in suppressing TGF-β/ALK5-mediated Smad3 activation. EMBO J. 2006;25(1):58-69. https://doi.org/10.1038/sj.emboj.7600917
Zhao M, Mishra L, Deng CX. The role of TGF-β/SMAD4 signaling in cancer. Int J Biol Sci. 2018;14(2):111-123. https://doi.org/10.7150/ijbs.23230
Lu Z, Sun N, Dong L, et al. Production of bioactive peptides from sea cucumber and its potential health benefits: a comprehensive review. J Agric Food Chem. 2022;70(25):7607-7625. https://doi.org/10.1021/acs.jafc.2c02696
Wargasetia TL, Ratnawati H, Widodo N, et al. Bioinformatics study of sea cucumber peptides as antibreast cancer through inhibiting the activity of overexpressed protein (EGFR, PI3K, AKT1, and CDK4). Cancer Informatics. 2021;20:1-11. https://doi.org/10.1177/11769351211031864
Assinder SJ, Dong Q, Kovacevic Z, et al. The TGF-β, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer. Biochem J. 2009;417(2):411-421. https://doi.org/10.1042/BJ20081610
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
